Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies

Treatment of multiple solitary plasmacytomas with cytokine-induced killer cells

(2014) Bo Yang et al.   CYTOTHERAPY

An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells

(2014) Clara E Jäkel et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors

(2014) Clara E. Jäkel et al.   Journal of Immunology Research

IL-15 Improves the Cytotoxicity of Cytokine-induced Killer Cells Against Leukemia Cells by Upregulating CD3+CD56+ Cells and Downregulating Regulatory T Cells As Well As IL-35

(2013) Qianshan Tao et al.   JOURNAL OF IMMUNOTHERAPY

A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission

(2012) Yeh-Ching Linn et al.   CYTOTHERAPY

IL-7 Abrogates Suppressive Activity of Human CD4+CD25+FOXP3+ Regulatory T Cells and Allows Expansion of Alloreactive and Autoreactive T Cells

(2012) A.-K. Heninger et al.   JOURNAL OF IMMUNOLOGY

Interleukin-6 Inhibits Regulatory T Cells and Improves the Proliferation and Cytotoxic Activity of Cytokine-induced Killer Cells

(2012) Guohe Lin et al.   JOURNAL OF IMMUNOTHERAPY

Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

(2011) Ginna G. Laport et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity

(2011) A. Pievani et al.   BLOOD

The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies

(2011) Y-C Linn et al.   BONE MARROW TRANSPLANTATION

Clinical Study of Autologous Cytokine-Induced Killer Cells for the Treatment of Elderly Patients with Diffuse Large B-Cell Lymphoma

(2011) Xue-chun Lu et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells

(2011) Eva Rettinger et al.   CYTOTHERAPY

Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial

(2011) Bo Yang et al.   HEMATOLOGICAL ONCOLOGY

Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one?

(2011) Sharmilan Thanendrarajan et al.   LEUKEMIA RESEARCH

Feasibility and Safety of Adoptive Immunotherapy with CIK Cells after Cord Blood Transplantation

(2010) Martino Introna et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

(2010) C. Hontscha et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

T Cell-Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective

(2009) A. Shablak et al.   CLINICAL CANCER RESEARCH

Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial

(2009) Paola Olioso et al.   HEMATOLOGICAL ONCOLOGY

Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers

(2008) Dario Sangiolo et al.   INTERNATIONAL IMMUNOLOGY